HoxB13 mediates AR-V7 activity in prostate cancer.
作者信息
Navarro Héctor I, Goldstein Andrew S
机构信息
Molecular Biology Interdepartmental Program, University of California, Los Angeles, CA 90095.
Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095;
出版信息
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6528-6529. doi: 10.1073/pnas.1808196115. Epub 2018 Jun 11.
Abstract
摘要
相似文献
1
HoxB13 mediates AR-V7 activity in prostate cancer.HoxB13在前列腺癌中介导AR-V7活性。
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6528-6529. doi: 10.1073/pnas.1808196115. Epub 2018 Jun 11.
2
Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.激素敏感性前列腺癌和去势抵抗性前列腺癌中雄激素受体变异体7和泛素结合酶2C的转录水平
Prostate. 2017 Jan;77(1):60-71. doi: 10.1002/pros.23248. Epub 2016 Aug 22.
3
HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.HOXB13作为激素激活的雄激素受体信号的抑制因子，可诱导前列腺癌细胞的生长抑制。
Cancer Res. 2004 Dec 15;64(24):9185-92. doi: 10.1158/0008-5472.CAN-04-1330.
4
Re: Diverse AR-V7 Cistromes in Castration-Resistant Prostate Cancer are Governed by HoxB13.回复：去势抵抗性前列腺癌中多样的AR-V7顺式作用元件受HoxB13调控
J Urol. 2019 Jan;201(1):33-34. doi: 10.1097/01.ju.0000550210.76901.34.
5
Re: Diverse AR-V7 Cistromes in Castration-Resistant Prostate Cancer are Governed by HoxB13.关于：去势抵抗性前列腺癌中多种AR-V7顺式作用元件受HoxB13调控
J Urol. 2019 Mar;201(3):446-447. doi: 10.1097/01.JU.0000553716.75971.4e.
6
Refining the Assessment and Implications of AR-V7 in Castrate-resistant Prostate Cancer.优化去势抵抗性前列腺癌中AR-V7的评估及其意义
Eur Urol. 2018 May;73(5):736-737. doi: 10.1016/j.eururo.2017.11.005. Epub 2017 Nov 20.
7
Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cells.糖原合酶激酶-3抑制剂可抑制AR-V7介导的转录，并选择性抑制AR-V7阳性前列腺癌细胞的生长。
Prostate. 2017 Jun;77(9):955-961. doi: 10.1002/pros.23351. Epub 2017 Apr 10.
8
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer.雄激素受体剪接变异体 AR-V7 的分支链 RNA 原位杂交作为转移性去势敏感性前列腺癌的预后生物标志物。
Clin Cancer Res. 2017 Jan 15;23(2):363-369. doi: 10.1158/1078-0432.CCR-16-0237. Epub 2016 Jul 20.
9
Prostate cancer: Exosomal AR-V7 is a marker of hormonal therapy resistance.前列腺癌：外泌体AR-V7是激素治疗耐药性的标志物。
Nat Rev Urol. 2016 Dec;13(12):695. doi: 10.1038/nrurol.2016.220. Epub 2016 Oct 25.
10
Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.雄激素受体剪接变体驱动的前列腺癌模型中睾酮的生长抑制作用
Prostate. 2016 Dec;76(16):1536-1545. doi: 10.1002/pros.23238. Epub 2016 Jul 30.
引用本文的文献
1
HOXB13 in cancer development: molecular mechanisms and clinical implications.HOXB13在癌症发展中的作用：分子机制与临床意义
Front Med. 2025 Mar 11. doi: 10.1007/s11684-024-1119-x.
2
Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers.了解 Pax5 在多西紫杉醇耐药神经内分泌样前列腺癌发展中的作用。
Cell Death Dis. 2024 Aug 25;15(8):617. doi: 10.1038/s41419-024-06916-y.
3
Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers.了解Pax5在紫杉烷耐药性神经内分泌样前列腺癌发展中的作用。
Res Sq. 2023 Dec 11:rs.3.rs-3464475. doi: 10.21203/rs.3.rs-3464475/v1.
4
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer.一种多价肽缩合物调节雄激素受体转录活性，抑制治疗抵抗性前列腺癌。
Mol Cancer Ther. 2023 Oct 2;22(10):1166-1181. doi: 10.1158/1535-7163.MCT-23-0196.
5
α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells.α-山竹黄酮促进前列腺癌细胞中雄激素受体及AR-V7剪接变体的体外和体内降解
Cancers (Basel). 2023 Apr 1;15(7):2118. doi: 10.3390/cancers15072118.
6
A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer.雄激素受体变体7靶基因及其在去势抵抗性前列腺癌中的作用简编
Front Oncol. 2023 Mar 1;13:1129140. doi: 10.3389/fonc.2023.1129140. eCollection 2023.
7
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.转移性去势抵抗性前列腺癌中的耐药性：现状更新
Cancer Drug Resist. 2022 Jun 22;5(3):667-690. doi: 10.20517/cdr.2022.15. eCollection 2022.
8
Urinary exosome-based androgen receptor-variant 7 detection in metastatic castration-resistant prostate cancer patients.基于尿液外泌体检测转移性去势抵抗性前列腺癌患者雄激素受体变异体7
Transl Androl Urol. 2022 Feb;11(2):202-212. doi: 10.21037/tau-21-1136.
9
Diverse Roles and Therapeutic Potentials of Circular RNAs in Urological Cancers.环状RNA在泌尿系统癌症中的多样作用及治疗潜力
Front Mol Biosci. 2021 Nov 19;8:761698. doi: 10.3389/fmolb.2021.761698. eCollection 2021.
10
HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma.HOXB13 和 TFF3 可有助于前列腺腺癌的预后分层。
Rom J Morphol Embryol. 2021 Jan-Mar;62(1):41-52. doi: 10.47162/RJME.62.1.04.
本文引用的文献
1
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.雄激素受体剪接变异体 7（AR-V7）在去势抵抗性前列腺癌（castration-resistant prostate cancer）中的不同染色质结构域受同源盒蛋白 B13（HoxB13）调控。
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6810-6815. doi: 10.1073/pnas.1718811115. Epub 2018 May 29.
2
Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study.伊朗亚兹德省前列腺癌导致的死亡率和寿命损失年数：一项为期10年的研究。
Sultan Qaboos Univ Med J. 2017 Nov;17(4):e424-e429. doi: 10.18295/squmj.2017.17.04.008. Epub 2018 Jan 10.
3
CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer.CTC 衍生的 AR-V7 检测作为晚期前列腺癌的预后和预测生物标志物。
Expert Rev Mol Diagn. 2018 Feb;18(2):155-163. doi: 10.1080/14737159.2018.1427068. Epub 2018 Jan 16.
4
Prostate cancer screening.前列腺癌筛查
Investig Clin Urol. 2017 Jul;58(4):217-219. doi: 10.4111/icu.2017.58.4.217. Epub 2017 Jun 20.
5
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.雄激素受体变体AR-V9在前列腺癌转移灶中与AR-V7共表达并预测阿比特龙耐药性。
Clin Cancer Res. 2017 Aug 15;23(16):4704-4715. doi: 10.1158/1078-0432.CCR-17-0017. Epub 2017 May 4.
6
Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice.了解前列腺特异性抗原动态变化在监测转移性去势抵抗性前列腺癌中的作用：对临床实践的启示
Asian J Androl. 2017 Mar-Apr;19(2):143-148. doi: 10.4103/1008-682X.179159.
7
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.TALEN 技术构建的 AR 基因重排揭示前列腺癌中雄激素受体的内分泌分离。
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17492-7. doi: 10.1073/pnas.1308587110. Epub 2013 Oct 7.
Zotero 插件